In line with a recent study, this supports the indispensable and non-redundant role of NK cells in cancer immunotherapy [22] and could be employed to reveal functional effects of NK cell stimulating therapies such as anti-NKG2A mAb [23] or interleukin 15 [24]. This evidence concerns the gene KLRC1 and cancer.